From medication delivery apps and patient monitoring tools to clinical trials acceleration, the digital health explosion has huge potential to transform pharma.
But amidst all the hype, where do the real opportunities lie?
Last week, four industry experts came together discuss the issues in this exclusive Health Tech World webinar.
The engaging debate explored a wide range of issues, including investment, regulatory challenges, logistics and barriers to wider tech adoption.
Many thanks to our panellists Janice MacLennan of NMBLR, Shameem C Hameed of blueBriX, Alistair Murray of Phlo and Becky Warnes of Becky Warnes Consultancy.
Stay tuned to Health Tech World in the coming days for an extensive write-up.
We’ll be running more webinars throught the year, with discussions on AI and oncology tabled for September.
Should your company have a voice around the table? Email [email protected] to get involved.
